Tempest Therapeutics, Inc. (TPST) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts TPST Hot Sheet
Join SI Premium – FREE
Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q1 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
